Task C1: Phase I Clinical Trial to Evaluate Influenza Therapeutics

$3,205,231N01FY2024AINIH

Allucent Government Services (Us) Llc, Cary NC

Investigators

McClenathan Brucecontact

View original record on NIH RePORTER →